UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
New coronavirus affect related stocks in different ways
by Jeong Sae-im
2020-01-30 17:36
Celltrion tops list of pharmaceutical brand reputation in January
by Jeong Sae-im
2020-01-30 16:10
Merck Korea worker commits suicide
by Kim Yun-mi
2020-01-30 16:09
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod
by Kim Yun-mi
2020-01-30 14:07
Hanmi targets revenue of ₩100 billion from Rosuzet sales
by Shim Hyun-tai
2020-01-29 18:05
라인
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk
by Park Gi-taek
2020-01-29 15:51
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’
by Kim Yun-mi
2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A
by Kim Yun-mi
2020-01-24 08:18
MIT promotes industrial liaison program to Korean drugmakers
by Jeong Sae-im
2020-01-23 12:04
'Reimbursement for Repatha to expand treatment options for ASCVD patients'
by Lee Han-soo
2020-01-22 15:14
라인
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019
by Kim Yun-mi
2020-01-22 15:10
HanAll remains positive of eye treatment’s efficacy despite initial failure
by Lee Han-soo
2020-01-21 15:12
SK Biopharma’s US partner gets EMA nod for sleepiness treatment
by Lee Han-soo
2020-01-21 14:22
Some Merck Korea workers commute from provinces to Seoul every day
by Kim Yun-mi
2020-01-21 14:21
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
by Jeong Sae-im
2020-01-21 11:43
라인
CoImmune acquires Formula Pharmaceuticals
by Lee Han-soo
2020-01-20 15:45
Pfizer’s spinoff of generics unit causes disputes with trade union
by Kim Yun-mi
2020-01-20 15:44
Korea’s botulinum toxin exports hit record high in 2019
by Jeong Sae-im
2020-01-20 11:38
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
by Kim Yun-mi
2020-01-17 17:30
GenScript to market Genopis' GMP-grade plasmid DNA
by Lee Han-soo
2020-01-17 17:28
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top